Publications

Management of Adverse Events in Patients with Acute Myeloid Leukemia in Remission Receiving Oral Azacitidine: Experience from the Phase 3 Randomized Quazar Aml-001 Trial

AuthID
P-00V-ASC

Author(s)

Ravandi, F

Roboz, GJ

Wei, AH

Dohner, H

Pocock, C

Selleslag, D

Montesinos, P

Sayar, H

Musso, M

Figuera Alvarez, A

[+2]·

Sohn, SK

Hiwase, D

Chevassut, T

Pierdomenico, F

La Torre, I

Skikne, B

Bailey, R

Zhong, JH

Beach, CL

Dombret, H

View all authors

Document Type

Article

Year published

2021

Published

in JOURNAL OF HEMATOLOGY & ONCOLOGY, ISSN: 1756-8722

Volume: 14, Issue: 1

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1186/s13045-021-01142-x

SCOPUS: 2-s2.0-85113742847

Wos: WOS:000690958700002

Source Identifiers

ISSN: 1756-8722

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Ravandi, F;	2	Roboz, GJ;	3	Wei, AH;
4	Dohner, H;	5	Pocock, C;	6	Selleslag, D;
7	Montesinos, P;	8	Sayar, H;	9	Musso, M;
10	Figuera Alvarez, A;	11	Safah, H;	12	Tse, W;
13	Sohn, SK;	14	Hiwase, D;	15	Chevassut, T;
16	Pierdomenico, F;	17	La Torre, I;	18	Skikne, B;
19	Bailey, R;	20	Zhong, JH;	21	Beach, CL;
22	Dombret, H;

Management of Adverse Events in Patients with Acute Myeloid Leukemia in Remission Receiving Oral Azacitidine: Experience from the Phase 3 Randomized Quazar Aml-001 Trial

Useful Links

Get Help

Federated Authentication (Click on the image)

Management of Adverse Events in Patients with Acute Myeloid Leukemia in Remission Receiving Oral Azacitidine: Experience from the Phase 3 Randomized Quazar Aml-001 Trial

Useful Links

Get Help